title: Efficacy of thalidomide in the treatment of myelodysplastic syndromes.
authors.forename: Pier Paolo
authors.initials: PP
authors.lastname: Piccaluga
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Visani
authors.forename: Carlo
authors.initials: C
authors.lastname: Finelli
authors.forename: Tiziana
authors.initials: T
authors.lastname: Grafone
authors.forename: Michele
authors.initials: M
authors.lastname: Baccarani
authors.forename: Sante
authors.initials: S
authors.lastname: Tura
mesh_terms: D000368:Aged; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D013792:Thalidomide / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D013810:Therapeutic Equivalency
chemical_list: D020533:Angiogenesis Inhibitors; D013792:Thalidomide